Products - Neuroendocrine tumours | Topic | NICE

Showing 2 products

Date | Title

Status: In developmentRemove ‘Status: In development’ filter

Cabozantinib for treating advanced neuroendocrine tumours that have progressed after systemic treatment [ID6474]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
21 May 2026
Lutetium oxodotreotide with octreotide for newly diagnosed unresectable or metastatic gastroenteropancreatic neuroendocrine tumours [ID6315]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC